166 related articles for article (PubMed ID: 12724616)
1. Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia.
Carlsson LE; Lubenow N; Blumentritt C; Kempf R; Papenberg S; Schröder W; Eichler P; Herrmann FH; Santoso S; Greinacher A
Pharmacogenetics; 2003 May; 13(5):253-8. PubMed ID: 12724616
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?
Karnes JH
Pharmacogenomics; 2018 Dec; 19(18):1413-1422. PubMed ID: 30398086
[TBL] [Abstract][Full Text] [Related]
4. Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?
Sucker C; Schmitz M; Hetzel GR; Grabensee B; Maruhn-Debowski B; Ostojic L; Scharf RE; Zotz RB
Clin Appl Thromb Hemost; 2009; 15(4):402-7. PubMed ID: 18502778
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke.
Carlsson LE; Greinacher A; Spitzer C; Walther R; Kessler C
Stroke; 1997 Jul; 28(7):1392-5. PubMed ID: 9227689
[TBL] [Abstract][Full Text] [Related]
6. Association of Platelet Membrane Glycoprotein HPA-2a/b, GP VI T13254C, and GP Ib
Ni W; He J; Wang H; Liu T
Biomed Res Int; 2017; 2017():1538750. PubMed ID: 28607925
[TBL] [Abstract][Full Text] [Related]
7. Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.
Kenny D; Muckian C; Fitzgerald DJ; Cannon CP; Shields DC
J Thromb Thrombolysis; 2002 Feb; 13(1):13-9. PubMed ID: 11994555
[TBL] [Abstract][Full Text] [Related]
8. Association of Polymorphisms in Coagulation Factor Genes and Enzymes of Homocysteine Metabolism With Arterial Ischemic Stroke in Children.
Coen Herak D; Lenicek Krleza J; Radic Antolic M; Horvat I; Djuranovic V; Zrinski Topic R; Zadro R
Clin Appl Thromb Hemost; 2017 Nov; 23(8):1042-1051. PubMed ID: 28301901
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced and drug-dependent immune thrombocytopenias.
Greinacher A; Eichler P; Lubenow N; Kiefel V
Rev Clin Exp Hematol; 2001 Sep; 5(3):166-200; discussion 311-2. PubMed ID: 11703814
[TBL] [Abstract][Full Text] [Related]
10. Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition.
Renna SA; Zhao X; Kunapuli SP; Ma P; Holinstat M; Boxer MB; Maloney DJ; Michael JV; McKenzie SE
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1808-1817. PubMed ID: 37345522
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
[TBL] [Abstract][Full Text] [Related]
12. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
Mousa SA; Ahmad S
Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
[TBL] [Abstract][Full Text] [Related]
13. Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.
Bolbrinker J; Garbe E; Douros A; Huber M; Bronder E; Klimpel A; Andersohn F; Meyer O; Salama A; Kreutz R
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1149-1155. PubMed ID: 28544026
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms of platelet membrane glycoprotein Ibα and risk of coronary heart disease in Han Chinese, Henan, China.
Zhang J; Zhao L; Lv P; Liu G; Du W; Yang F; Du Y; Zhao L
Int J Clin Exp Pathol; 2015; 8(5):6005-11. PubMed ID: 26191334
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia: pathophysiology and clinical concerns.
Greinacher A
Baillieres Clin Haematol; 1998 Jun; 11(2):461-74. PubMed ID: 10097820
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis.
Liu H; Wang Y; Zheng J; Li G; Chen T; Lei J; Mao Y; Wang J; Liu W; Zhao G; Tacey M; Yan B
Int J Stroke; 2017 Jan; 12(1):46-70. PubMed ID: 28004990
[TBL] [Abstract][Full Text] [Related]
17. Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.
Mikkelsson J; Perola M; Penttilä A; Karhunen PJ
Circulation; 2001 Aug; 104(8):876-80. PubMed ID: 11514372
[TBL] [Abstract][Full Text] [Related]
18. An update on heparin-induced thrombocytopenia: diagnosis and management.
Bakchoul T
Expert Opin Drug Saf; 2016 Jun; 15(6):787-97. PubMed ID: 26966871
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarction.
Ozelo MC; Origa AF; Aranha FJ; Mansur AP; Annichino-Bizzacchi JM; Costa FF; Pollak ES; Arruda VR
Thromb Haemost; 2004 Aug; 92(2):384-6. PubMed ID: 15269835
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia: a ten-year retrospective.
Warkentin TE
Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
